BC Clinical impact of medication reviews with follow‐up in cardiovascular older patients in primary care: A cluster‐randomized controlled trial
Open Access
- 16 February 2023
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 89 (7) , 2131-2143
Abstract
Aims: Cardiovascular diseases (CVD) are the primary cause of death in Chile. Pharmacist‐led medication review with follow‐up (MRF) has improved CVD risk factors control in Europe and North America. However, their healthcare systems differ from Chile's, precluding generalizability. This trial aimed to determine the effect of MRF on CVD risk factor control among older patients with polypharmacy attending public primary care centres in Chile.Methods: A cluster‐randomized controlled trial was conducted in 24 centres. Patients older than 65 years with moderate‐to‐high CVD risk, five or more medications, hypertension, type 2 diabetes or dyslipidaemia, received MRF in addition to usual care or usual care alone for 12 months. Primary outcome measures were clinical goal achievement for hypertension, type 2 diabetes and dyslipidaemia, as well as medication adherence, medication number and CVD risk score. Adjusted generalized estimating equations were used, with odds ratios (ORs) for binary measures and mean differences for continuous measures.Results: In total, 324 patients from 12 centres (174 MRF group, 150 usual care group, six centres each) received four pharmacist visits. Significant improvements were found for goal achievement in hypertension (OR 4.37, 95% confidence interval [CI] 2.54 to 7.51, P = .001), LDL cholesterol (OR 3.67, 95% CI 2.13 to 6.33, P = .001), type 2 diabetes (OR 6.97, 95% CI 3.69 to 13.2, P = .001), medication adherence (OR 6.60, 95% CI 1.36 to 31.9, P = .022), medications number (−0.86, 95% CI −1.14 to −0.58, P < .001) and CVD risk score (−2.27, 95% CI −2.84 to −1.69, P < .001).Conclusion: Pharmacist‐led medication review with follow‐up improved cardiovascular disease risk factor control and medication adherence. This study supports pharmacists' inclusion in primary care teams.Keywords
Funding Information
- University of Technology Sydney (196385)
This publication has 18 references indexed in Scilit:
- Priority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting – Analysis of a Cluster Randomized Controlled Trial (WestGem-Study)PLOS ONE, 2016
- Evaluating Pharmacist-Written Recommendations to Providers in a Medicare Advantage Plan: Factors Associated with Provider AcceptanceJournal of Managed Care & Specialty Pharmacy, 2016
- Quality and Reporting of Cluster Randomized Controlled Trials Evaluating Occupational Therapy InterventionsOTJR: Occupational Therapy Journal of Research, 2015
- Methods for sample size determination in cluster randomized trialsInternational Journal of Epidemiology, 2015
- To adjust or not to adjust for baseline when analyzing repeated binary responses? The case of complete data when treatment comparison at study end is of interestPharmaceutical Statistics, 2015
- Analysis of Partially Observed Clustered Data using Generalized Estimating Equations and Multiple ImputationThe Stata Journal: Promoting communications on statistics and Stata, 2014
- Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with AtherosclerosisThe American Journal of Medicine, 2013
- Consort 2010 statement: extension to cluster randomised trialsBMJ, 2012
- Practice Change in Community Pharmacy: Quantification of FacilitatorsAnnals of Pharmacotherapy, 2008
- Cluster randomized controlled trials in primary care: An introductionEuropean Journal of General Practice, 2006